Valeant Pharmaceuticals International Inc (NYSE:VRX)

18.58
Delayed Data
As of Feb 20
 -0.30 / -1.59%
Today’s Change
8.31
Today|||52-Week Range
24.43
-10.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-462.3M629.0M-41.7M1.4B
 
 
 
 
 
Depreciation649.1M674.0M656.4M799.9M
 
 
 
 
 
Total Other Cash Flow262.4M-25.0M-144.7M229.2M
 
 
 
 
 
Funds From Operations530.4M324.0M226.6M497.3M
 
 
 
 
 
Funds From/For Other Operating Expenses58.1M-592.0M-31.1M-77.0M
 
 
 
 
 
Net Cash Flow - Operating Activities472.4M916.0M257.7M574.3M
 
 
 
 
 
 
InvestingIncrease In Investments431.2K0.00-992.1K-3.2M
 
 
 
 
Decrease In Investments95.8K0.00992.1K1.1M
 
 
 
 
Capital Expenditures-50.8M-38.0M-36.4M-48.9M
 
 
 
 
 
Fixed Asset Disposal63.9M1.3B810.1M1.1B
 
 
 
 
 
Net Assets From Acquisitions 30.7M-9.0M9.0M0.00
 
 
 
 
Other Investing - Uses-29.8M0.000.000.00
 
 
Net Cash Flow Investing9.5M1.1B773.8M1.0B
 
 
 
 
 
 
FinancingShort Term Borrowings3.1M-1.0M-5.9M-1.4M
 
 
 
 
 
Long Term Borrowings-20.9M6.2B-51.1M327.2M
 
 
 
 
 
Long Term Debt Reduction-488.9M-7.6B-158.3M-1.9B
 
 
 
 
 
Net Proceeds Stock Sale-669.6K0.000.000.00
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total--0.000.000.00--
Other Sources - Financing----------
Other Uses - Financing39.7M9.0M28.7M20.8M
 
 
 
 
 
Net Cash Flow - Financing-538.7M-1.4B-244.0M-1.6B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-60.1M8.0M15.8M16.9M
 
 
 
 
 
 
Net Change In Cash-56.7M660.0M787.5M2.7M